Cas9 Stable Cell Line - HEK293T

HEK293T is a highly versatile human embryonic kidney cell line that stably expresses the SV40 large T antigen, making it one of the most widely used tools in biomedical research due to its excellent transfectability and robust protein expression. The Cas9 Stable Cell Line - HEK293T takes this workhorse cell line a step further by constitutively expressing the Streptococcus pyogenes Cas9 nuclease, eliminating the need for transient transfection or viral delivery of the Cas9 component in CRISPR experiments. These cells are generated through lentiviral transduction followed by antibiotic selection, resulting in a homogeneous population that maintains stable Cas9 expression over many passages. Researchers can directly introduce single guide RNAs (sgRNAs) via standard transfection methods and immediately achieve efficient gene editing without the variability and extra steps associated with co-delivering Cas9 and sgRNA simultaneously.

This cell line is particularly well suited for high-throughput functional genomics screens, where consistent Cas9 expression across all experimental conditions is critical for reproducibility. It is also widely used for generating knockout cell pools or clonal lines to study gene function, identify drug targets, and validate candidate genes involved in disease pathways. The constitutive Cas9 expression streamlines workflows for both loss-of-function and gain-of-function studies, especially when combined with sgRNA libraries or donor templates for homology-directed repair. Beyond basic research, the Cas9 HEK293T stable line supports applications in synthetic biology, viral production, and protein engineering, where reliable and efficient genome editing can significantly accelerate experimental timelines.